Non-Hodgkin lymphoma (NHL) can sound overwhelming, but what does it really mean for patients and families? In this episode, we speak to Dr. Jean Koff of Winship Cancer Institute of Emory University, who breaks down the big picture of NHL: what it is, how it’s an umbrella term for multiple subtypes, and what today’s treatments and tomorrow’s innovations could mean for you. From understanding subtypes and staging to exploring options like watchful waiting, chemotherapy, and cutting-edge immunotherapies, we cover what matters most: knowledge, clarity, and hope.

Mentioned on this episode: 

• Non-Hodgkin lymphoma
• The Lymphoma Guide
• Lugano staging system
• Immunotherapy fact sheet
• CAR T-cell therapy
• Allogeneic stem cell transplantation
• Clinical Trial Support Center
• Online NHL Chat

Additional Blood Cancer United Support Resources: 

• Free Nutrition Consultations
• Information Specialists 
• Financial support
• Free telephone/web patient programs 
• Free booklets 
• Young Adult Resources
• Support groups 
• Caregiver support 
• Caregiver Workbook
• Survivorship Workbook
• Advocacy and Public Policy
• Patient Community
• Mental Health Resources

Supported by AbbVie Inc. and Genentech, A Member of the Roche Group.

The post The Big Picture on Non-Hodgkin Lymphoma: Treatments, Trends, and Tomorrow first appeared on The Bloodline with Blood Cancer United Podcast.